<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04927078</url>
  </required_header>
  <id_info>
    <org_study_id>287454</org_study_id>
    <nct_id>NCT04927078</nct_id>
  </id_info>
  <brief_title>Analysis of Vital Signs in Patients With COVID-19</brief_title>
  <official_title>Analysis of Vital Signs in Patients With COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oxehealth Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Brompton &amp; Harefield NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oxehealth Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will use data obtained from a proprietary vision-based patient monitoring and&#xD;
      management system (OxeVision) for measuring heart rate and respiratory rate which is in&#xD;
      clinical use at the Coventry and Warwickshire Partnership NHS Trust.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will analyse data from patients with known COVID 19 infection both during,&#xD;
      and where possible before clinical COVID 19 infection and controls to determine whether&#xD;
      changes can be detected in these parameters that precede overt clinical deterioration. The&#xD;
      role of remote vision-based patient monitoring and management in supporting the care of&#xD;
      patients with COVID-19 will be assessed through staff interviews.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Actual">October 31, 2020</completion_date>
  <primary_completion_date type="Actual">October 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Breathing rates</measure>
    <time_frame>Data will be collected throughout study completion, an average of 7 months, to obtain breathing rate before and after the diagnosis of COVID 19.</time_frame>
    <description>Breathing rates collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulse rates</measure>
    <time_frame>Data will be collected throughout study completion, an average of 7 months, to obtain pulse rate before and after the diagnosis of COVID 19.</time_frame>
    <description>Pulse rate collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BR and PR</measure>
    <time_frame>Data will be collected throughout study completion, an average of 7 months, to obtain breathing and pulse rate before and after the diagnosis of COVID 19.</time_frame>
    <description>Similar data to be collected from control subjects</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Respiratory Disease</condition>
  <arm_group>
    <arm_group_label>Participants with COVID 19 diagnosis</arm_group_label>
    <description>We will measure the breathing rate (BR) before and after the clinical diagnosis of COVID 19.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Participants without COVID 19 diagnosis</arm_group_label>
    <description>Breathing rates will be measured for the same time duration as the cases.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation of breathing pattern</intervention_name>
    <description>Observations will be collected using a remote vision based patient monitoring and management system.</description>
    <arm_group_label>Participants with COVID 19 diagnosis</arm_group_label>
    <arm_group_label>Participants without COVID 19 diagnosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult participants admitted to inpatient mental health wards.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients age 18 and above. Patients on wards with a medical diagnosis of COVID 19 who&#xD;
             are in rooms with the Vision based patient monitoring and management system.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Children will be excluded. No data will be excluded unless specifically requested by the&#xD;
        treating clinician.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Polkey</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Royal Bromptom Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coventry and Warwickshire Partnership NHS</name>
      <address>
        <city>Coventry</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>June 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2021</study_first_posted>
  <last_update_submitted>June 14, 2021</last_update_submitted>
  <last_update_submitted_qc>June 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breathing rate</keyword>
  <keyword>Pulse rate</keyword>
  <keyword>COVID 19</keyword>
  <keyword>Patient monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

